Recombinant Interferon Alpha 2b-like Protein
Sponsors
M.D. Anderson Cancer Center, Thomas Jefferson University
Conditions
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8Recurrent Breast CarcinomaRefractory Breast CarcinomaStage III Hepatocellular Carcinoma AJCC v8Stage IIIA Hepatocellular Carcinoma AJCC v8Stage IIIB Hepatocellular Carcinoma AJCC v8
Phase 1
Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer
RecruitingNCT04380545
Start: 2021-01-13End: 2028-02-28Target: 15Updated: 2026-09-14
Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast Cancer
WithdrawnNCT04418219
Start: 2020-12-21End: 2024-01-01Updated: 2025-04-29